Study Details

Back
Study ID FJ-506D-AC10
Study Title Phase III, Long-Term, Open-Label, Extension Study of Tacrolimus(FK506) Ophthalmic Suspension in Patients with Vernal Keratoconjunctivitis(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier NCT00567918
Compound Name FK506 / tacrolimus
Medical Indication or Disease Vernal keratoconjunctivitis
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 08-May-2004
Study Completion Date 27-Feb-2008
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS